Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1986-07-30
1989-02-28
Warden, Robert J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514312, 514313, 514314, 546 18, 546153, 546159, A61K 3147, C07D21518, C07D21542
Patent
active
048086193
ABSTRACT:
Compounds of the formula ##STR1## as defined in the specification, and processes for their preparation and methods of using the compounds for the treatment of hypertension in mammals, such as humans and for the treatment and/or prophylaxis of cerebrovascular disorders and/or disorders associated with cerebral senility in mammals, such as humans.
REFERENCES:
patent: 4416113 (1984-05-01), Evans et al.
patent: 4427680 (1984-01-01), Friebe
patent: 4510152 (1985-04-01), Faruk
patent: 4657910 (1987-04-01), Morgan
Bentue-Ferrer et al., Experimental Aging Research, 11, 137-141 (1985).
Angersbach Dieter
Evans John M.
Nicholson Charles D.
Stemp Geoffrey
Beecham Group p.l.c.
Benson Robert
Warden Robert J.
LandOfFree
Di/tetra-hydroquinolines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Di/tetra-hydroquinolines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Di/tetra-hydroquinolines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1367534